CADTH launches post-market drug evaluation program

CADTH

1 September 2022 - CADTH is pleased to announce the launch of its new post-market drug evaluation program.

This important initiative fills a key gap in Canada’s drug safety and effectiveness landscape and is an exciting example of how CADTH is delivering on the “Innovate” pillar from its 2022-2025 Strategic Plan.

Read CADTH News

Michael Wonder

Posted by:

Michael Wonder